The General Hospital Corporation and Affymetrix | Date: 2015-02-13
Methods for diagnosing and treating IgG4-related disease (IgG4-RD), e.g., based on detecting levels of IgG4 mRNA, preferably using a branched DNA assay.
Affymetrix | Date: 2015-03-23
Methods for multiplex amplification of a plurality of targets of distinct sequence from a complex mixture are disclosed. In one aspect targets are circularized using a single circularization probe that is complementary to two regions in the target that flank a region to be amplified. The targets may hybridize to the circularization probe so that 5 or 3 flaps are generated and methods for removing flaps and circularizing the resulting product are disclosed. In another aspect targets are hybridized to dU probes so that 5 and 3 flaps are generated. The flaps are cleaved using 5 or 3 flap endonucleases or 3 to 5 exonucleases. The target sequences are then ligated to common primers, the dU probes digested and the ligated targets amplified.
The General Hospital Corporation and Affymetrix | Date: 2015-02-27
The present application relates to methods for diagnosing and treating multiple myeloma (MM) and non-Hodgkin lymphoma (NHL), e.g., based on the detection of clonal IgK or IgL-expressing cells.
Affymetrix | Date: 2015-02-18
The present invention provides methods, compositions, and kits for storing and enhancing the activity of polymerases and particularly thermostable polymerases. The methods comprise mixing a thermostable polymerase with at least one zwitterionic or ylide surfactant that has at least one PEO group. In another aspect the polymerase is mixed with a blocker such as PLURONIC or TETRONIC or an amine N-oxide derivative thereof. The thermostable polymerase may be reversibly inactivated by treatment with 2-(Methylsulfonyl)ethyl 4-nitrophenyl carbonate. Compositions and kits for performing the process according to the invention are also provided.
Affymetrix | Date: 2015-08-14
Methods of detecting nucleic acids, including methods of detecting nucleic acids in situ, are provided. The methods can detect even target nucleic acids that are partially degraded and/or masked by extensive crosslinking. Compositions, kits, and systems related to the methods are also described